Agueda Donato-Ferrer
Toledo, CM 45071, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
White adipose tissue undergoes pathological dysfunction in the TDP-43A315T mouse model of amyotrophic lateral sclerosis (ALS).
Journal: Acta neuropathologica communications
Published: June 26, 2025
Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone.
Journal: ACS biomaterials science & engineering
Published: October 14, 2022
Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS).
Journal: International journal of molecular sciences
Published: August 09, 2021
The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS).
Journal: Brain and behavior
Published: August 02, 2021
Methodology Aspects of Colony Maintain for a Murine Model of Amyotrophic Lateral Sclerosis (ALS) TDP-43 Proteinopathy.
Journal: Animals : an open access journal from MDPI
Published: October 30, 2020
Early treatment with UR13870, a novel inhibitor of p38α mitogenous activated protein kinase, prevents hyperreflexia and anxiety behaviors, in the spared nerve injury model of neuropathic pain.
Journal: Neuroscience letters
Published: June 19, 2015
Oral 2-hydroxyoleic acid inhibits reflex hypersensitivity and open-field-induced anxiety after spared nerve injury.
Journal: European journal of pain (London, England)
Published: April 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026